Nia Beckley, MD

Photo of Nia Beckley, MD
Title(s)Resident Physician, Medicine
SchoolSchool of Medicine
Address600 16th Street, #N472C
San Francisco CA 94158
ORCID ORCID Icon0000-0002-7957-598 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    MIT, Cambridge, MassBS06/2007Biological Chemical Engineering
    MIT, Cambridge, MassM Eng06/2009Biological Engineering
    Stanford, Stanford, CaMD06/2021Medicine
    UCSF, San Francisco, CaResidency06/2023Medicine

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A Phase II Trial of Pembrolizumab plus Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Biliary Cancer. Clin Cancer Res. 2026 Aug 14. Kelley RK, Bracci P, Gordan JD, Behr SC, Quandt Z, Atreya CE, Kidder WA, Ko AH, Lim HC, Van Loon K, Adeniji N, Venook AP, Fong L, Keenan BP. PMID: 42599167.
      View in: PubMed   Mentions:
    2. Author Correction: Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver. Nature. 2025 Dec; 648(8093):E9. Fan W, Adebowale K, Váncza L, Li Y, Rabbi MF, Kunimoto K, Chen D, Mozes G, Chiu DK, Li Y, Tao J, Wei Y, Adeniji N, Brunsing RL, Dhanasekaran R, Singhi A, Geller D, Lo SH, Hodgson L, Engleman EG, Charville GW, Charu V, Monga SP, Kim T, Wells RG, Chaudhuri O, Török NJ. PMID: 41310314; PMCID: PMC12695621.
      View in: PubMed   Mentions:    Fields:    
    3. Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual disease. Nat Cancer. 2024 Oct; 5(10):1534-1556. Lemaitre L, Adeniji N, Suresh A, Reguram R, Zhang J, Park J, Reddy A, Trevino AE, Mayer AT, Deutzmann A, Hansen AS, Tong L, Arjunan V, Kambham N, Visser BC, Dua MM, Bonham CA, Kothary N, D'Angio HB, Preska R, Rosen Y, Zou J, Charu V, Felsher DW, Dhanasekaran R. PMID: 39304772; PMCID: PMC12258040.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    4. Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver. Nature. 2024 02; 626(7999):635-642. Fan W, Adebowale K, Váncza L, Li Y, Rabbi MF, Kunimoto K, Chen D, Mozes G, Chiu DK, Li Y, Tao J, Wei Y, Adeniji N, Brunsing RL, Dhanasekaran R, Singhi A, Geller D, Lo SH, Hodgson L, Engleman EG, Charville GW, Charu V, Monga SP, Kim T, Wells RG, Chaudhuri O, Török NJ. PMID: 38297127; PMCID: PMC10866704.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansAnimalsCells
    5. MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages. Cancer Res. 2023 02 15; 83(4):626-640. Dhanasekaran R, Hansen AS, Park J, Lemaitre L, Lai I, Adeniji N, Kuruvilla S, Suresh A, Zhang J, Swamy V, Felsher DW. PMID: 36525476; PMCID: PMC9931653.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    6. Non-alcoholic Fatty Liver Disease and Liver Fibrosis during Aging. Aging Dis. 2022 Jul 11; 13(4):1239-1251. Li Y, Adeniji NT, Fan W, Kunimoto K, Török NJ. PMID: 35855331; PMCID: PMC9286912.
      View in: PubMed   Mentions: 31     Fields:    
    7. Genomic Landscape of HCC. Curr Hepatol Rep. 2020 Dec; 19(4):448-461. Nia A, Dhanasekaran R. PMID: 33816052; PMCID: PMC8015384.
      View in: PubMed   Mentions: 22  
    8. Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study. Clin Gastroenterol Hepatol. 2021 Jul; 19(7):1469-1479.e19. Kim D, Adeniji N, Latt N, Kumar S, Bloom PP, Aby ES, Perumalswami P, Roytman M, Li M, Vogel AS, Catana AM, Wegermann K, Carr RM, Aloman C, Chen VL, Rabiee A, Sadowski B, Nguyen V, Dunn W, Chavin KD, Zhou K, Lizaola-Mayo B, Moghe A, Debes J, Lee TH, Branch AD, Viveiros K, Chan W, Chascsa DM, Kwo P, Dhanasekaran R. PMID: 32950749; PMCID: PMC7497795.
      View in: PubMed   Mentions: 151     Fields:    Translation:Humans
    9. MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity. Elife. 2020 01 14; 9. Dhanasekaran R, Baylot V, Kim M, Kuruvilla S, Bellovin DI, Adeniji N, Rajan Kd A, Lai I, Gabay M, Tong L, Krishnan M, Park J, Hu T, Barbhuiya MA, Gentles AJ, Kannan K, Tran PT, Felsher DW. PMID: 31933479; PMCID: PMC6959993.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    10. Cathepsin B Cleavage of vcMMAE-Based Antibody-Drug Conjugate Is Not Drug Location or Monoclonal Antibody Carrier Specific. Bioconjug Chem. 2016 Apr 20; 27(4):1040-9. Gikanga B, Adeniji NS, Patapoff TW, Chih HW, Yi L. PMID: 26914498.
      View in: PubMed   Mentions: 15     Fields:    Translation:Cells
    Nia's Networks
    Concepts (63)
    Derived automatically from this person's publications.
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _